A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy (September, 10.1038/s41417-020-00225-0, 2020)

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Automated summary

The paper has been amended and the revised version can be accessed through a link at the top of the paper.